Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

19

Number of overlapping holdings

21.3%

% of WDNA's 91 holdings also in SYNB

55.9%

% of SYNB's 36 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus SYNB)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in SYNB
Overlap
ELI LILLY & CO 1.9% 3.8% 1.9%
TWIST BIOSCIENCE CORP. 3.4% 1.7% 1.7%
VERTEX PHARMACEUTICALS INC 1.3% 1.4% 1.3%
DANAHER CORP 1.3% 7.2% 1.3%
REGENERON PHARMACEUTICALS 1.2% 3.1% 1.2%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to SYNB
IOVANCE BIOTHERAPEUTICS INC 3.9%
FATE THERAPEUTICS INC 3.1%
NOVOZYMES A/S-B SHARES 2.4%
BLUEPRINT MEDICINES CORP. 2.2%
BRIDGEBIO PHARMA, INC. 2.0%
NATERA INC 1.9%
ALCOBRA LTD 1.7%
VERICEL CORPORATION 1.7%
TWIST BIOSCIENCE CORP. 1.7%
AGIOS PHARMACEUTICALS INC 1.6%
WDNA Underweight Relative to SYNB
NVIDIA CORP -7.3%
THERMO FISHER SCIENTIFIC INC -6.5%
DANAHER CORP -5.9%
ALPHABET INC. CLASS A -5.2%
BIO-RAD LABORATORIES-CL A -4.8%
NOVOZYMES A/S-UNSPONS ADR -4.6%
ABBVIE INC -4.4%
ASCENDIS PHARMA A/S -4.1%
CORTEVA INC -3.5%
AVANTOR, INC. -3.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY